This bill would create a maternal health monitoring pilot program within the New York State Department of Health to provide remote patient monitoring for pregnant Medicaid recipients enrolled in participating managed care organizations. The program is aimed at improving care for maternal hypertension and maternal diabetes during pregnancy and for up to three months postpartum. It defines eligible participants, participating managed care organizations, technology vendors, and the clinical care team that would monitor data and provide coaching and coordination with obstetric and maternal-fetal medicine providers.
Under the bill, the Department of Health would select participating managed care organizations and a technology vendor, and the vendor would be required to supply FDA-authorized monitoring devices, train participants, and support a clinical team that reviews readings and triggers escalation when needed. The pilot would operate in enough counties to serve up to 500 eligible participants, including counties identified as maternity care deserts, and would begin within 180 days after contract execution. The program would run for two years, with a $600,000 state contribution to offset costs, and the department would pay fees to managed care organizations to administer the program.
The bill would also require a formal evaluation of the pilot within two years of implementation. That report would analyze claims, vital statistics, and electronic health record data to assess effects on maternal, fetal, and neonatal outcomes, including maternal mortality, severe maternal morbidity, preeclampsia, cesarean rates, ICU use, fetal growth restriction, neonatal mortality, NICU admissions, preterm birth, and birthweight. The report would also assess whether the program produces Medicaid savings and recommend whether the pilot should be expanded statewide.
The bill’s impact on state law would be to add a new section to the Public Health Law establishing a state-run pilot program and authorizing the Department of Health to administer, contract for, and evaluate remote monitoring services for a defined Medicaid population. It would affect pregnant Medicaid enrollees, managed care organizations, technology vendors, and maternal health providers, particularly in underserved areas with limited maternity care access. Because it is a pilot, the bill does not permanently expand benefits statewide, but it creates a framework for testing remote monitoring as a covered maternal health intervention.
The available context shows no recorded committee debate or votes, so there is no documented opposition or support in the provided materials. Based on the bill text, the measure appears policy-driven and preventive, with an emphasis on improving maternal outcomes and addressing disparities in maternity care access. Any likely contention would center on program cost, administrative complexity, data-sharing and privacy concerns, and whether the pilot’s evidence would justify broader expansion.
The bill would amend the Public Health Law by adding a new section establishing a maternal health monitoring pilot program in the Department of Health. It authorizes the department to select participating managed care organizations and a technology vendor, requires remote monitoring services for eligible pregnant Medicaid recipients, and mandates a post-pilot evaluation and report. The measure would directly affect Medicaid managed care administration, remote patient monitoring services, and maternal care delivery for pregnant enrollees, especially in maternity care deserts.
No committee transcripts or vote records were provided, so there is no formal recorded sentiment from legislative discussion. Based on the bill’s structure and findings-oriented design, the measure appears generally supportive of maternal health improvement, with a focus on preventive care, postpartum monitoring, and access in underserved counties. The absence of recorded opposition suggests no documented controversy in the provided materials, though the pilot nature indicates a cautious, evidence-gathering approach rather than an immediate statewide mandate.
Because there are no transcripts or votes in the provided context, no specific points of contention are documented. Potential areas of debate implied by the bill include the $600,000 state cost, the role of managed care organizations and a private technology vendor, the handling of patient health data transmitted through cellular networks, and whether remote monitoring can meaningfully improve outcomes enough to justify expansion. Another possible issue is the bill’s focus on Medicaid recipients, which may raise questions about scope and equity if the pilot proves successful.